Precision Biologics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of a large-scale copper mining operation in Chile, reflecting investor focus on Antofagasta PLC shares, Q1 2026 production stability, and the Centinela Second Concentrator growth story.

Antofagasta (LSE: ANTO) surges 5% as Q1 output beats consensus and Centinela build holds schedule

Shubman Gill’s 86 steers Gujarat Titans past Kolkata Knight Riders in IPL 2026

Kizik debuts Freedom Run, betting step-in technology can break into performance running

Kizik launches Freedom Run as it pushes hands-free footwear into the performance running market

Representative image of industrial equipment and specialty vehicles, illustrating the Terex Corporation (NYSE: TEX) stock story as investors watch whether the post-merger machinery giant can keep climbing into May 1 earnings.

Can Terex Corporation (NYSE: TEX) keep climbing into May 1 earnings?

Representative image of CAR-NK therapy targeting acute myeloid leukemia, illustrating the AACR 2026 story on Precision Biologics’ newly presented AML antigen approach.

Read More

Pharma Industry News

AACR 2026: Precision Biologics says it found a new weak spot in AML for CAR-NK therapy

Precision Biologics has revealed a new AML CAR-NK target at AACR 2026. Read why truncated O-glycans could matter for future leukemia therapy.

byPallavi Madhiraju

April 17, 2026

web analytics